Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
Tags:
clinical trials
,
Pfizer
,
Roche
,
idanacogene elaparvovec
,
Alexion
,
AstraZeneca
,
Ultomiris
,
AbbVie
,
Rinvoq
,
Novartis
,
sabatolimab
Roche Scores Wins in AMD & COVID-19 in Big Week
BioSpace
Sun, 06/27/21 - 12:02 am
Tags:
Roche
,
Genentech
,
COVID-19
,
wet age-related macular degeneration
FDA allows emergency use of Roche’s Actemra for Covid-19
Pharmaceutical Business Review
Fri, 06/25/21 - 11:06 am
Tags:
Roche
,
Actemra
,
COVID-19
,
Emergency Use Authorization
Roche's Genentech launches new alliance aimed at achieving greater diversity in cancer trials
Fierce Biotech
Thu, 06/24/21 - 11:02 am
Tags:
Roche
,
Genentech
,
clinical trials
,
clinical trial diversity
,
cancer
,
Advancing Inclusive Research Site Alliance
Roche eyes October decision by FDA for wet AMD implant
Pharmaforum
Thu, 06/24/21 - 11:00 am
Tags:
Roche
,
FDA
,
wet age-related macular degeneration
,
ranibizumab
Arcus declares cryptic interim win for closely watched anti-TIGIT drug, but you'll have to wait for the data
Endpoints
Wed, 06/23/21 - 10:32 pm
Tags:
Arcus Biosciences
,
anti-TIGIT
,
Roche
Roche's Alzheimer's antibody lowers biomarkers in inherited form of disease, though impact on symptoms is unclear
Fierce Biotech
Mon, 06/21/21 - 11:08 am
Tags:
Roche
,
gantenerumab
,
Alzheimer's disease
,
clinical trials
,
biomarkers
Novartis touts latest Zolgensma data as SMA competition against Biogen, Roche heats up
Fierce Pharma
Sun, 06/20/21 - 10:21 pm
Tags:
Novartis
,
SMA
,
spinal muscular atrophy
,
Zolgensma
,
Roche
,
Evresdi
Eli Lilly, Roche's Alzheimer's prospects, including flops, boosted in light of FDA's Aduhelm approval: analysts
Fierce Biotech
Fri, 06/11/21 - 12:10 pm
Tags:
Eli Lilly
,
Roche
,
Biogen
,
Alzheimer's disease
,
FDA
,
beta-amyloid plaque
Roche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey
Fierce Pharma
Mon, 06/7/21 - 08:29 pm
Tags:
cancer
,
patients
,
COVID-19
,
pandemic
,
Roche
,
Pfizer
,
Novartis
Analysts throw cold water on Exelixis and Roche's prostate cancer data, putting the pair a further step behind Novartis
Endpoints
Tue, 05/25/21 - 11:08 am
Tags:
Exelixis
,
Cabometyx
,
Roche
,
Tecentriq
,
prostate cancer
Roche's Spark sues gene therapy rival bluebird for using 'spark' in its marketing campaigns
Fierce Pharma
Thu, 05/20/21 - 11:15 am
Tags:
Roche
,
Spark Therapeutics
,
Bluebird Bio
,
gene therapy
,
trademark
Roche CEO Schwan joins chorus of pharma execs blasting COVID patent waiver
Fierce Pharma
Fri, 05/14/21 - 10:54 am
Tags:
Roche
,
Severin Schwan
,
Pharma CEOs
,
COVID-19
,
vaccines
,
intellectual property
Validation for a drug class, and for Sanofi
EP Vantage
Wed, 05/12/21 - 10:44 am
Tags:
Sanofi
,
Serds
,
breast cancer
,
Amcenestrant
,
Radius Health
,
Elacestrant
,
Roche
,
Giredestrant
,
AstraZeneca
,
Camizestrant
Merck, Roche and Bristol Myers nab 4 of 6 positive ODAC votes for ‘dangling’ accelerated approvals
Endpoints
Thu, 04/29/21 - 10:55 pm
Tags:
Merck
,
Roche
,
Bristol Myers Squibb
,
FDA
,
ODAC
,
accelerated approvals
,
Keytruda
,
Opdivo
,
Tecentriq
ODAC votes to keep Keytruda and Tecentriq accelerated approvals in bladder cancer
Endpoints
Wed, 04/28/21 - 10:12 pm
Tags:
FDA
,
ODAC
,
accelerated approvals
,
Merck
,
Keytruda
,
Roche
,
Tecentriq
Zolgensma flatlines, but Spinraza isn’t the beneficiary
EP Vantage
Wed, 04/28/21 - 10:27 am
Tags:
SMA
,
Biogen
,
Novartis
,
Roche
,
Spinraza
,
Zolgensma
,
Evrysdi
What caused Roche's Huntington's drug tominersen to hit the skids in late-stage test? It's complicated, analysts say
Endpoints
Wed, 04/28/21 - 10:22 am
Tags:
Roche
,
Huntington's disease
,
tominersen
FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now
Fierce Pharma
Tue, 04/27/21 - 11:37 pm
Tags:
Roche
,
Tecentriq
,
Abraxane
,
breast cancer
,
FDA
,
accelerated approvals
What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?
Fierce Pharma
Tue, 04/27/21 - 11:04 am
Tags:
FDA
,
oncology
,
accelerated approvals
,
Merck
,
Keytruda
,
Bristol Myers Squibb
,
Opdivo
,
Roche
,
Tecentriq
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.